[12] Patent
[11] Patent No.:GC0007632  
[45] Date of Publishing the Grant of the Patent: 30/Apr /2018                48/2018  
Number of the Decision to Grant the Patent:2018/126257
Date of the Decision to Grant the Patent:22/Apr/2018

[21] Application No.:GC 2011-19687

[22] Filing Date:12/11/2011

[30] Priority:

[33] State [32] Priority date [31] Priority No.
US
10/11/2010
61/412,064

[72] Inventors:1- John Vincent Calienni،2- Baoqing Gong،3- Prasad Koteswara Kapa،4- Guang-Pei Chen،5- Vishal Saxena

[73] Owners:1- Astex Therepeutics Ltd., 436 Cambridge Science Park, Milton Road, CB4 0QA, Cambridge, United Kingdom،2- Novartis AG, Lichtstrasse 35, 4056, Basel, Switzerland

[74] Agent: Saud M. A. Shawwaf Law Office

  

 

  

[51]IPC:
Int. Cl.: [C07D401/12] (2006.01)

[56] Cited Documents:

-WO 2010/020675 A1 (NOVARTIS AG [CH]; ASTEXTHERAPEUTICS LTD [GB]; BESONG GILBERT[GB]; BR) 25 February 2010
-WO 2006/008545 A2 (ASTEX THERAPEUTICS LTD[GB]; BERDINI VALERIO [GB]; EARLY THERESARACHA) 26 January 2006
-WO 2007/075783 A2 (WYETH CORP [US]; TSOUHWEI-RU [US]; AYRAL-KALOUSTIAN SEMIRAMIS[US]; 8) 05 July 2007
 
Examiner: PH. Sultana K. AlOudah

[54] SALTS OF 7-CYCLOPENTYL-2-5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOF
[57] Abstract: This invention relates to (1) process of making 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and salts thereof; (2) novel salt(s) of 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide; (3) pharmaceutical compositions comprising the same; and (4) methods of treatment using the same.
No. of claims: 10     No. of figures: 6


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.